Rss Lifescience Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.79 M
- Company Age 14 Year, 11 Months
- Last Filing with ROC 31 Mar 2014
- Open Charges ₹ 0.80 M
- Satisfied Charges ₹ 0.60 M
About Rss Lifescience
Rss Lifescience Private Limited (RLPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 February 2010 and has a history of 14 years and 11 months. Its registered office is in 24 Parganas, West Bengal, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2014. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.79 M.
The company currently has active open charges totaling ₹0.80 M. The company has closed loans amounting to ₹0.60 M, as per Ministry of Corporate Affairs (MCA) records.
Debkanya Datta and Manas Barman serve as directors at the Company.
Company Details
-
Location
24 Parganas, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24240WB2010PTC142078
-
Company No.
142078
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
11 Feb 2010
-
Date of AGM
30 Sep 2014
-
Date of Balance Sheet
31 Mar 2014
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Rss Lifescience?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Debkanya Datta
|
Additional Director | 23-Feb-2015 | Current |
|
Manas Barman
|
Additional Director | 23-Feb-2015 | Current |
Financial Performance of Rss Lifescience.
Enhance accessibility to Rss Lifescience's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rss Lifescience?
Unlock access to Rss Lifescience's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹0.80 M
₹0.60 M
Charges Breakdown by Lending Institutions
- United Bank Of India : 0.08 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Nov 2013 | United Bank Of India | ₹0.80 M | Open |
| 22 Mar 2011 | State Bank Of India | ₹0.60 M | Satisfied |
How Many Employees Work at Rss Lifescience?
Unlock and access historical data on people associated with Rss Lifescience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rss Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rss Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
